|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-5-4
|
|
pubmed:abstractText |
To establish the toxicities and maximum tolerated dose of paclitaxel given over 3 h in combination with cisplatin, to determine the pharmacokinetic profiles of these two drugs and to observe their antitumor activity, we conducted a combination phase I study in non-small cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
pubmed-author:KakinumaRR,
pubmed-author:KodamaTT,
pubmed-author:KubotaKK,
pubmed-author:KunitohHH,
pubmed-author:KurataTT,
pubmed-author:MatsumotoTT,
pubmed-author:NishiwakiYY,
pubmed-author:OheYY,
pubmed-author:OmatsuHH,
pubmed-author:SaijoNN,
pubmed-author:ShinkaiTT,
pubmed-author:TamuraTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11336328-Adult,
pubmed-meshheading:11336328-Aged,
pubmed-meshheading:11336328-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11336328-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11336328-Cisplatin,
pubmed-meshheading:11336328-Drug Administration Schedule,
pubmed-meshheading:11336328-Female,
pubmed-meshheading:11336328-Humans,
pubmed-meshheading:11336328-Lung Neoplasms,
pubmed-meshheading:11336328-Male,
pubmed-meshheading:11336328-Middle Aged,
pubmed-meshheading:11336328-Paclitaxel
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer.
|
|
pubmed:affiliation |
Thoracic Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
